Desmopressin vs Melanotan II
Overview
Desmopressin is primarily a hormonal peptide, while Melanotan II is used for cosmetic & skin.
This page compares Desmopressin and Melanotan II across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Desmopressin | Melanotan II | |
|---|---|---|
| Category | Hormonal | Cosmetic & Skin |
| Regulatory status (US) | FDA approved | Not approved — Cat. 2 removed (Apr 2026) |
| Typical dosage | 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) | — |
| Frequency | Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia) | — |
| Reported benefits | central diabetes insipidus management, primary nocturnal enuresis in children, nocturia due to nocturnal polyuria, perioperative hemostasis in mild hemophilia A, hemostasis in Type I von Willebrand disease, management of polyuria following head trauma or pituitary surgery | Skin tanning without UV exposure, increased libido, potential appetite suppression |
| Reported side effects | hyponatremia (boxed warning), headache, facial flushing, nausea, abdominal cramps, fluid retention, hypotension, reflex tachycardia, hypertension, tachyphylaxis with repeated dosing, rare anaphylaxis | Nausea, facial flushing, darkening of moles, potential cardiovascular effects |
Key differences
Primary use. Desmopressin is categorised under Hormonal, while Melanotan II falls under Cosmetic & Skin. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Desmopressin: FDA-approved. Melanotan II: not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
Dosing. Desmopressin is typically dosed at 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) (Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia)). Typical dosing for Melanotan II is not catalogued.
Can you stack them?
Some protocols combine peptides, but stacking Desmopressin and Melanotan II has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Desmopressin and Melanotan II?
- Desmopressin is primarily a hormonal peptide, while Melanotan II is used for cosmetic & skin. Desmopressin is FDA-approved for one or more indications, whereas Melanotan II is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
- What is Desmopressin used for?
- Synthetic ADH analog (DDAVP) FDA-approved for diabetes insipidus, nocturnal enuresis, and bleeding disorders.
- What is Melanotan II used for?
- Tanning, libido.
- Can you take Desmopressin and Melanotan II together?
- Some users combine peptides within a single protocol, but stacking Desmopressin and Melanotan II has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Desmopressin or Melanotan II FDA-approved?
- Desmopressin is FDA-approved for one or more indications. Melanotan II is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
Read the full articles
- Desmopressin — full monograph: mechanism, research, dosing & references
- Melanotan II — full monograph: mechanism, research, dosing & references